PT-141+ Sublingual Strips feature a multi-compound formulation of PT-141 (2 mg per strip), Oxytocin (25 mcg per strip), and Aminophenpyrrole (20 mg per strip) in a fast-dissolving format, developed to support preclinical research into peptide–small molecule interactions, compound compatibility, and presentation stability within controlled laboratory environments.
PT-141 (bremelanotide) is a synthetic melanocortin receptor agonist, while Oxytocin is a neuropeptide involved in social and behavioral signaling pathways. Aminophenpyrrole is a small-molecule compound examined in non-clinical research models for its role in neuromodulatory and receptor-associated frameworks. Together, these compounds have been referenced in scientific literature for their potential interactions across central signaling and neurochemical response pathways.
The sublingual strip format provides a consistent, low-mess presentation designed for standardized handling and repeatable study protocols across research settings.
FOR RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION. This product has not been evaluated by the Food and Drug Administration and is not intended to diagnose, treat, cure, or prevent any disease. Bodily introduction into humans or animals is strictly prohibited by law.
Alpha Biomed is not a compounding pharmacy or chemical compounding facility as defined under 503a of the federal food, drug, and cosmetic act. Alpha Biomed is not an outsourcing facility as defined under 503b of the federal food, drug, and cosmetic act.
Choosing a selection results in a full page refresh.
